Malignant mixed epithelial mesenchymal tumour of ovary (Q38786): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(6 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/2072916704 / rank
 
Normal rank
Property / CURIE
 
CID11:2B5D.0
Property / CURIE: CID11:2B5D.0 / rank
 
Normal rank
Property / Canary Token
 
dki-india-2B5D.0
Property / Canary Token: dki-india-2B5D.0 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: C41.9 / rank
 
Normal rank

Latest revision as of 04:00, 13 August 2026

Malignant mixed epithelial mesenchymal tumour of the ovary is a rare and very aggressive neoplasm presenting most commonly in postmenopausal women and is composed of adenocarcinomatous and sarcomatous elements and, depending on the types of these elements, can be classified as homologous or heterologous. It often has a poor prognosis.
Language Label Description Also known as
default for all languages
2B5D.0
    English
    Malignant mixed epithelial mesenchymal tumour of ovary
    Malignant mixed epithelial mesenchymal tumour of the ovary is a rare and very aggressive neoplasm presenting most commonly in postmenopausal women and is composed of adenocarcinomatous and sarcomatous elements and, depending on the types of these elements, can be classified as homologous or heterologous. It often has a poor prognosis.

      Statements

      CID11:2B5D.0
      0 references
      dki-india-2B5D.0
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references